Fuan Pharmaceutical Group Co - Asset Resilience Ratio

Latest as of March 2026: 3.02%

Fuan Pharmaceutical Group Co (300194) has an Asset Resilience Ratio of 3.02% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Fuan Pharmaceutical Group Co short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥170.12 Million

≈ $24.89 Million USD Cash + Short-term Investments

Total Assets

CN¥5.63 Billion

≈ $824.31 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Fuan Pharmaceutical Group Co's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300194 total assets.

Liquid Assets Composition Over Time

This chart breaks down Fuan Pharmaceutical Group Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Fuan Pharmaceutical Group Co to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥170.12 Million	3.02%
Total Liquid Assets	CN¥170.12 Million	3.02%

Asset Resilience Insights

Limited Liquidity: Fuan Pharmaceutical Group Co maintains only 3.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Fuan Pharmaceutical Group Co Industry Peers by Asset Resilience Ratio

Compare Fuan Pharmaceutical Group Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Fuan Pharmaceutical Group Co (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Fuan Pharmaceutical Group Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.60%	CN¥150.05 Million ≈ $21.96 Million	CN¥5.76 Billion ≈ $843.37 Million	+2.10pp
2024-12-31	0.50%	CN¥30.00 Million ≈ $4.39 Million	CN¥5.98 Billion ≈ $874.85 Million	+0.42pp
2023-12-31	0.08%	CN¥5.05 Million ≈ $739.50K	CN¥5.98 Billion ≈ $874.47 Million	-0.17pp
2022-12-31	0.26%	CN¥15.21 Million ≈ $2.23 Million	CN¥5.88 Billion ≈ $860.13 Million	-0.11pp
2021-12-31	0.37%	CN¥20.86 Million ≈ $3.05 Million	CN¥5.71 Billion ≈ $835.03 Million	-0.90pp
2020-12-31	1.27%	CN¥75.67 Million ≈ $11.07 Million	CN¥5.97 Billion ≈ $874.01 Million	-2.90pp
2019-12-31	4.17%	CN¥197.31 Million ≈ $28.87 Million	CN¥4.74 Billion ≈ $693.02 Million	+2.86pp
2018-12-31	1.30%	CN¥56.00 Million ≈ $8.19 Million	CN¥4.29 Billion ≈ $628.14 Million	-6.10pp
2017-12-31	7.40%	CN¥347.00 Million ≈ $50.78 Million	CN¥4.69 Billion ≈ $686.12 Million	+3.28pp
2016-12-31	4.12%	CN¥181.00 Million ≈ $26.49 Million	CN¥4.40 Billion ≈ $643.51 Million	-11.07pp
2015-12-31	15.18%	CN¥376.42 Million ≈ $55.08 Million	CN¥2.48 Billion ≈ $362.77 Million	--

pp = percentage points

About Fuan Pharmaceutical Group Co

SHE:300194 China Drug Manufacturers - Specialty & Generic

Market Cap

$658.07 Million

CN¥4.50 Billion CNY

Market Cap Rank

#10956 Global

#3039 in China

Share Price

CN¥3.78

Change (1 day)

-0.53%

52-Week Range

CN¥3.34 - CN¥4.76

All Time High

CN¥10.53